How Seaweed Helps Reduce Plaque in Dogs: The Science of Ascophyllum nodosum

A happy brown dog in front of seaweed with text about the role of seaweed in canine dental care.

Dogs accumulate dental plaque quickly—often long before an owner notices a smell. Once plaque (a living bacterial biofilm) begins to mineralise into tartar (dental calculus), its rough surface provides a scaffold for further bacterial growth, inflammation and worsening odour. Periodontal disease is extremely common in dogs, particularly with age and in smaller breeds.

One evidence-based, “hands-off” approach that has gained attention in veterinary research is the use of a dietary seaweed—Ascophyllum nodosum—as a daily additive. Importantly, this ingredient does not act like a toothpaste or mechanical cleaner. Instead, the best available evidence suggests a systemic effect after ingestion, with changes expressed through saliva and biofilm behaviour over time.

Blue banner asking: “Seaweed can improve my dog’s bad breath?”

What is Ascophyllum nodosum and why is it used in canine dentistry?

Ascophyllum nodosum (often called “rockweed”) is a brown seaweed found in North Atlantic coastal regions.

From a functional nutrition perspective, it is notable for its naturally complex composition. It contains a range of polysaccharides—including fucoidans, alginates, laminarin and mannitol—as well as phenolic compounds such as phlorotannins. As with all seaweeds, this composition can vary depending on location and season, which is why processing and formulation play an important role in consistency.

In veterinary dentistry, A. nodosum is used as a passive home-care ingredient, typically added to food on a daily basis. A recent veterinary review summarised that oral supplementation has been shown (in dogs and cats) to reduce plaque and calculus, with early metabolomic evidence suggesting changes in saliva composition. Importantly, the strongest evidence supports its role in slowing the recurrence of plaque and tartar after professional cleaning, rather than acting as a rapid remover of established deposits.

Informational graphic stating that dogs evolved with natural plaque control from chewing, but modern soft diets reduce this defense, with a simple dog illustration.

How seaweed reduces plaque and bad breath in dogs

It targets plaque as a biofilm problem, not just “dirty teeth”

In dogs, plaque is a structured biofilm that develops in stages. Early colonising bacteria (often facultative anaerobes using salivary glycoproteins) help establish conditions for later colonisers—typically more strictly anaerobic, protein-degrading organisms—leading to increased pathogenic potential over time.

Because plaque behaves as a biofilm, effective control is not just about removal, but about disruption of key processes, including bacterial growth and metabolism, microbial adhesion and co-aggregation, and biofilm matrix formation and maturation.

One important group of brown seaweed compounds—phlorotannins—has demonstrated antimicrobial and anti-biofilm activity in multiple in vitro models. These compounds have been shown to inhibit bacterial growth and interfere with biofilm formation and quorum sensing, with proposed mechanisms involving interactions with membrane proteins and key enzymes.

In the pivotal canine clinical trial discussed below, researchers noted that the observed effects were unlikely to be explained by chewing or mechanical action (given the small size and number of pieces). Instead, they pointed towards a chemical or metabolic mechanism—consistent with a biofilm-targeted mode of action.

A fluffy white dog with a thick coat smiling with its tongue out outdoors.

It may shift “saliva chemistry” in ways that make plaque and calculus less likely to form

Saliva is a complex biological fluid—primarily produced by salivary glands, but also containing components from mucosa, gingival fluid, microbes and their metabolites. Importantly, certain compounds from the bloodstream can enter saliva depending on their size and chemical properties, providing a pathway through which diet can influence the oral environment from the inside out.

In a double-blind, placebo-controlled dog study examining saliva metabolomics, 30 days of Ascophyllum nodosum supplementation resulted in clear shifts in the saliva metabolome. Notably, an algae-derived sterol (isofucosterol) was detected after supplementation, supporting the idea that ingested seaweed compounds—or their metabolites—can be absorbed and later appear in saliva.

The authors proposed a plausible mechanism in which bioactive compounds are absorbed in the intestine and subsequently secreted into the oral cavity via saliva, where they may influence biofilm behaviour.

A veterinary review similarly highlights saliva modification as a promising therapeutic pathway, noting that diet can influence oral pH, microbiome composition, immune activity and mineral balance—all of which can affect plaque accumulation and calculus formation

It may reduce tartar by slowing plaque mineralisation and altering calculus structure

Dental calculus is essentially mineralised plaque. During its formation, bacterial activity contributes to local increases in calcium and phosphate concentrations, triggering mineral deposition. Once formed, calculus can mechanically irritate tissues and create a rough surface that promotes further bacterial adhesion.

In human studies, daily ingestion of Ascophyllum nodosum has been associated with reduced calculus formation, as well as deposits described as more porous and easier to remove. This points towards an effect on mineralisation dynamics and deposit structure, rather than simple surface-level removal.

In dogs, controlled studies similarly report reduced calculus indices over time following supplementation (see next section), supporting a role in slowing accumulation rather than removing established deposits.

Blue textured graphic asking: “True or False: Dental supplements only work if they physically scrape the teeth.”

It can reduce bad breath by reducing volatile sulphur compounds

“Dog breath” associated with periodontal disease is largely driven by microbial metabolism of protein substrates, which produces volatile sulphur compounds (VSCs) such as hydrogen sulphide and methyl mercaptan. These compounds are well established as key contributors to oral malodour and are linked to periodontal disease processes.

In the canine clinical trial of A. nodosum treats, VSC levels were measured and showed significant reductions in the seaweed group at later timepoints. This aligns with improvements in plaque and calculus indices, suggesting that changes in biofilm composition and activity contribute to improved breath over time.

Why this is systemic, not topical

Seaweed dental supplements are mixed into food and swallowed—they do not coat teeth or act like a toothpaste. The available evidence supports a systemic mechanism, where effects are mediated through the body and expressed in the oral environment.

Three independent lines of evidence support this:

  • Canine clinical trial findings: Researchers concluded that the observed effects were unlikely to be due to mechanical action, given the small size and number of treat pieces, and instead suggested a chemical or metabolite-driven mechanism following ingestion.

  • Saliva metabolomics in dogs: A controlled study demonstrated that compounds derived from Ascophyllum nodosum (or their metabolites) appeared in saliva after supplementation, supporting intestinal absorption followed by secretion into the oral cavity.

  • Human clinical evidence: A randomised cross-over trial similarly concluded that A. nodosum exerts systemic effects on oral health, reinforcing the biological plausibility of this pathway.

Taken together, these findings support a model in which ingested seaweed compounds influence saliva composition and biofilm behaviour, rather than acting through direct contact with the tooth surface.

Blue textured graphic explaining that dental supplements can work systemically through bioactive compounds absorbed and affecting the mouth via saliva.

What the research says

Double-blind randomised controlled trial in dogs using A. nodosum treats

A 90-day double-blind, randomised, placebo-controlled study in 60 client-owned small-breed dogs evaluated daily edible treats containing Ascophyllum nodosum following professional dental cleaning at baseline. Dogs received either placebo treats or seaweed-containing treats (25% w/w), dosed according to body weight.

Key outcomes:

  • Plaque index: plaque increased in both groups post-cleaning (as expected), but was significantly lower in the seaweed group at day 90 (reported means 2.71 vs 1.67). 
  • Calculus index: calculus accumulation was significantly lower in the seaweed group at days 30, 60 and 90. 
  • VSCs (breath marker): VSC levels diverged after the first month; by days 60 and 90 the seaweed group showed significantly lower VSC scores. The authors also reported percentage reductions in VSC levels in the seaweed group over time. 
  • Gingival bleeding index: differences between groups emerged later, with a significant between-group difference at day 90. 

Because all dogs received a professional dental cleaning at baseline, this study design reflects real-world use. The findings support Ascophyllum nodosum as a strategy to slow the re-accumulation of plaque and calculus over time, rather than acting as an instant remover of established tartar.

Chart comparing plaque buildup over time showing lower accumulation in dogs given Ascophyllum nodosum versus a control group.

Double-blind randomised controlled trial in dogs showing saliva metabolome changes

A separate double-blind, randomised, placebo-controlled study evaluated 30 days of powdered Ascophyllum nodosum supplementation (versus placebo) in dogs, analysing non-stimulated whole saliva using QTOF mass spectrometry.

The authors reported clear differences in the saliva metabolome after supplementation. Notably, an algae-derived sterol (isofucosterol) was detected in saliva following supplementation—supporting a biologically plausible saliva-mediated systemic mechanism, where ingested compounds (or their metabolites) are absorbed and later expressed in the oral environment.

A relevant safety consideration was also highlighted: dogs with elevated thyroxine levels were excluded from the study due to the iodine content of the seaweed. This reinforces the importance of appropriate dosing and caution in dogs with thyroid-related conditions.

Veterinary review synthesis

A 2023 veterinary review of Ascophyllum nodosum use in dogs and cats concluded that supplementation has evidence for reducing plaque and calculus following oral administration. It also highlights early metabolomic findings suggesting changes in saliva composition, and supports its use after professional dental cleaning to help reduce recurrence, rather than as a rapid treatment for established deposits.

Human randomised controlled cross-over trial supporting systemic calculus effects

While not a canine study, a randomised cross-over trial in adults taking 500 mg/day dried Ascophyllum nodosum reported reduced supragingival calculus formation, along with reductions in plaque and gingival bleeding.

The authors also noted that calculus appeared more porous and easier to remove, suggesting an effect on mineralisation dynamics rather than surface-level removal. Importantly, they concluded that the alga’s effects were systemic—supporting the same saliva-mediated mechanism proposed in canine studies.

Canident dental supplement container with text promoting benefits beyond dental care and a call-to-action to “Add to Bowl.”

Quality and sourcing considerations

Species matters—but composition and control matter more in practice

“Seaweed” is not a single ingredient. Different species vary in iodine content and bioactive composition, which can influence how they behave in nutritional and functional applications.

For dental outcomes, the strongest canine evidence is specifically linked to the brown seaweed Ascophyllum nodosum, rather than generic “kelp” or unspecified seaweed blends.

At the same time, composition can vary even within a single species depending on sourcing, season and processing. In practice, this means that how a seaweed ingredient is selected, processed and standardised is just as important as the species itself.

Whole seaweed powder vs extracts

Commercial products may use dried whole seaweed (the full thallus) milled into powder, or incorporate extracts that concentrate specific components.

Seaweed chemistry is inherently complex. Ascophyllum nodosum contains a range of compounds—including alginates, fucoidans, laminarin, mannitol and polyphenols—which can vary depending on source and processing.

Extraction methods can influence which of these components are retained or concentrated. A veterinary review notes that both the composition and bioactivity of A. nodosum extracts can vary depending on how they are produced.

In practice, this means that whole powders and extracts are not directly interchangeable, and the form alone does not determine effectiveness.

If you are evaluating an extract-based product, useful indicators include:

  • some level of standardisation (e.g. to key compound groups such as polyphenols or fucoidan)

  • transparency around processing or extraction approach

  • batch testing for iodine and contaminants

Ultimately, the most important factor is not whether a product uses a powder or an extract, but whether the ingredient is consistently produced and appropriately controlled.

Processing and contamination control

Seaweeds naturally absorb minerals from their environment, which means they can also accumulate undesirable elements such as heavy metals. In addition, iodine levels can vary depending on species, harvest conditions and processing.

Commercial production of Ascophyllum nodosum typically involves steps such as harvesting, washing, drying and milling, alongside quality control processes designed to reduce contamination risks.

In practice, responsible sourcing and processing should ensure that seaweed ingredients are:

  • harvested from monitored environments

  • processed under controlled conditions

  • tested for contaminants and iodine at batch level

This is what translates raw seaweed into a consistent and reliable ingredient for use in dog nutrition.

A close-up of a tan dog with soft eyes looking calmly at the camera in a green outdoor setting.

What “European standards” should practically mean for pet seaweed

In Europe, feed ingredients are required to be safe, traceable and produced under controlled conditions. This includes legal limits for undesirable substances such as arsenic, cadmium, lead and mercury, as well as requirements for manufacturing standards and product traceability.

In practical terms, for a seaweed-based dental ingredient, “meeting European standards” should translate into:

  • sourcing from monitored and appropriate harvest regions

  • batch-level testing for contaminants (e.g. heavy metals)

  • control and verification of iodine levels

  • manufacturing under recognised quality systems (e.g. GMP or HACCP principles)

  • clear documentation and traceability throughout the supply chain

These are not marketing claims—they are the baseline for turning a naturally variable raw material into a consistent and reliable ingredient.

Extraction technologies and bioavailability

When extracts are used, the method of extraction can influence which compounds are present and in what concentrations.

Modern extraction approaches (including techniques such as ultrasound-assisted extraction) are increasingly studied for their ability to recover specific groups of bioactive compounds from brown seaweeds like Ascophyllum nodosum. Research shows that extraction conditions can affect yields of compounds such as polyphenols and fucoidan.

In practice, this means that extraction is not just a technical detail—it directly influences the composition of the final ingredient, and therefore how it may interact with biological systems such as oral biofilms.

As with whole seaweed, the key consideration is not the extraction method itself, but whether the resulting ingredient is consistent, characterised and appropriately controlled.

Dosing and usage guidance

This is general educational information, not medical advice. Dogs with active dental disease or pain need veterinary assessment.

What dosing looks like in clinical research

In the 90-day randomised controlled trial, dogs received daily treats dosed by body weight, each containing a defined amount of Ascophyllum nodosum. Outcomes improved over time, with some measures diverging more clearly after 60–90 days.

In the 30-day saliva metabolomics study, powdered supplementation (based on manufacturer guidance) resulted in a daily intake of approximately 33–82.5 mg/kg body weight and produced clear changes in the saliva metabolome.

Practical usage patterns

Most veterinary summaries position Ascophyllum nodosum as a daily adjunct for home dental care, particularly following professional cleaning to help slow the recurrence of plaque and calculus.

Owners should set expectations appropriately:

  • It is not an instant “scale-off” product.

  • Benefits develop over weeks to months, consistent with how plaque re-accumulates and how oral biofilm and saliva dynamics change over time.

Safety considerations and contraindications

Canident product packaging with a note highlighting batch-tested iodine content of 332 mg/kg (0.03%).

Iodine and thyroid considerations

Iodine is an essential nutrient required for thyroid hormone production, but both insufficient and excessive intake can disrupt thyroid function.

This is relevant because brown seaweeds can contain high and variable levels of iodine depending on species, sourcing and processing. Nutritional guidance for dogs includes defined ranges for iodine intake within complete diets, reflecting the importance of maintaining appropriate levels.

Practical considerations:

  • If a dog has known or suspected thyroid disease, or is on thyroid medication, consult a veterinarian before introducing seaweed supplements.

  • When using multiple products that may contribute iodine, adjust overall intake rather than combining full doses, so that total exposure remains appropriate.

Contaminants and testing

Seaweeds can accumulate heavy metals and other environmental contaminants. As a result, quality control is an essential part of safe use.

Choose products that are:

  • sourced from monitored environments

  • produced under controlled manufacturing systems

  • tested for contaminants and iodine on a batch basis

Tolerance

In the 90-day canine study, dogs completed the trial without clinically observed adverse effects, and no digestive issues were reported by owners. This is reassuring, but individual tolerance may vary—particularly depending on the overall formulation of the product.

Ascophyllum nodosum can reduce plaque accumulation, tartar formation and breath-related volatile sulphur compounds in dogs when used consistently. The strongest evidence comes from controlled canine studies, and supports a systemic mechanism, where ingested compounds influence saliva chemistry and biofilm behaviour rather than acting through direct mechanical cleaning.

In practice, outcomes depend on consistent use, appropriate formulation and overall dietary context. While the clinical evidence is strongest for Ascophyllum nodosum, other brown seaweeds contain related classes of bioactive compounds, and may contribute to a broader compositional profile when used in well-designed formulations.

When iodine levels are appropriately managed and ingredients are quality controlled, seaweed can be a safe and effective adjunct to brushing and veterinary dental care—particularly for slowing recurrence after professional cleaning.

FAQs

Does seaweed replace tooth brushing for plaque control?

No. Brushing remains the most effective way to mechanically disrupt plaque on a daily basis. Seaweed should be viewed as a supportive, passive adjunct rather than a replacement.

How long does Ascophyllum nodosum take to improve dog breath?

In controlled studies, breath-related markers began to separate more clearly over 60–90 days, reflecting gradual changes in plaque accumulation and oral biofilm dynamics rather than an immediate effect.

Will it remove existing tartar?

Current evidence supports reducing the re-accumulation of plaque and calculus after professional cleaning. It is not designed to rapidly remove established, mineralised tartar.

Is it safe for dogs with thyroid disease?

Caution is warranted. Brown seaweeds can be a source of iodine, and clinical studies have excluded dogs with altered thyroid function. Veterinary guidance is recommended before use in dogs with thyroid disease or those receiving thyroid medication.

Why does the seaweed species matter?

“Seaweed” is a broad category, and different species vary significantly in composition. The strongest canine dental evidence relates specifically to Ascophyllum nodosum, while other brown seaweeds contain related bioactive compounds but may differ in composition and iodine levels. In practice, how the ingredient is selected and formulated is what determines its role.

References

  1. Gawor, J., Jank, M., Jodkowska, K., Klim, E., Svensson, U.K. (2018). Effects of edible treats containing Ascophyllum nodosum on the oral health of dogs: a double-blind, randomized, placebo-controlled study. Frontiers in Veterinary Science. 
  2. Gawor, J.P., Wilczak, J.W., Svensson, U.K., Jank, M. (2021). Influence of dietary supplementation with a powder containing A.N. ProDen™ (Ascophyllum nodosum) algae on dog saliva metabolome. Frontiers in Veterinary Science. 
  3. Gawor, J., Jank, M. (2023). Ascophyllum nodosum as a nutrient supporting oral health in dogs and cats: a review. Polish Journal of Veterinary Sciences. 
  4. van Dijken, J.W.V., Koistinen, S., Ramberg, P. (2015). Daily intake of Ascophyllum nodosum and effects on calculus, plaque and gingival variables: a randomised controlled cross-over study. Clinical Oral Investigations. 
  5. Li, X., et al. (2025). Compositional changes and comparative analysis of oral microbial community during the formation of canine dental calculus. Animals. 
  6. Rawlings, J.M., Culham, N. (1998). Halitosis in dogs and the effect of periodontal therapy. Journal of Nutrition. 
  7. Monteiro, M., Sloth, J., Holdt, S., Hansen, M. (2019). Analysis and Risk Assessment of Seaweed. EFSA Journal (EU-FORA report). 
  8. ANSES (2018). Opinion on the risk of excess iodine intake from the consumption of seaweed in foodstuffs. ANSES Scientific Opinion. 
  9. FEDIAF (2025). Nutritional Guidelines for Complete and Complementary Pet Food for Cats and Dogs. FEDIAF Guidance Document. 
  10. European Commission (2015). Commission Regulation (EU) 2015/186 amending Annex I to Directive 2002/32/EC on undesirable substances in animal feed. Official Journal of the European Union. 
  11. Tamanai-Shacoori, Z., Chandad, F., Rébillard, A., Cillard, J., Bonnaure-Mallet, M. (2014). Polyphenol-rich extracts of Ascophyllum nodosum and effects relevant to periodontal biofilms and inflammation (in vitro). PLOS ONE. 
  12. Pacheco, D., et al. (2022). Evidence and perspectives on phlorotannins as antimicrobial and anti-biofilm molecules. Medical Sciences Forum. 
  13. Pozharitskaya, O., et al. (2024). Ascophyllum nodosum from Arctic: biochemical composition and safety considerations (elements, polysaccharides, polyphenols). Marine Drugs. 
  14. Obluchinskaya, E., Pozharitskaya, O.N. (2023). Ultrasound-assisted extraction of fucoidan from Fucales including Ascophyllum nodosum. Journal of Applied Phycology. 
  15. MSD Veterinary Manual (updated 2024). Disorders of the thyroid gland in dogs. MSD Veterinary Manual.